Invesco Ltd. Cuts Stock Position in Semler Scientific Inc. $SMLR

Key Points

• Invesco Ltd. has significantly reduced its stake in Semler Scientific Inc. by 91.2%, now holding only 9,705 shares worth approximately $351,000.
• Several institutional investors, including BNP Paribas and Driehaus Capital Management LLC, have recently increased their investments in Semler Scientific, indicating a strong interest from larger entities.
• Semler Scientific reported impressive quarterly earnings, achieving $5.04 EPS, which exceeded analysts' expectations and demonstrated a return on equity of 43.84% with a net margin of 86.20%.

Invesco Ltd. lessened its position in shares of Semler Scientific Inc. (NASDAQ:SMLR - Free Report) by 91.2% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 9,705 shares of the company's stock after selling 100,736 shares during the quarter. Invesco Ltd. owned approximately 0.10% of Semler Scientific worth $351,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also made changes to their positions in the company. Deutsche Bank AG increased its holdings in Semler Scientific by 82.0% in the first quarter. Deutsche Bank AG now owns 4,893 shares of the company's stock valued at $177,000 after purchasing an additional 2,204 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of Semler Scientific by 226.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 158,576 shares of the company's stock worth $5,740,000 after buying an additional 109,951 shares in the last quarter. Pacer Advisors Inc. acquired a new position in Semler Scientific during the first quarter valued at approximately $1,874,000. Cetera Investment Advisers raised its holdings in shares of Semler Scientific by 26.7% in the 1st quarter. Cetera Investment Advisers now owns 22,654 shares of the company's stock valued at $820,000 after purchasing an additional 4,775 shares during the period. Finally, SBI Securities Co. Ltd. lifted its position in shares of Semler Scientific by 161.3% in the first quarter. SBI Securities Co. Ltd. now owns 959 shares of the company's stock valued at $35,000 after buying an additional 592 shares during the last quarter. Institutional investors and hedge funds own 49.37% of the company's stock.

Analysts Set New Price Targets

SMLR has been the subject of several analyst reports. Cantor Fitzgerald dropped their price objective on Semler Scientific from $61.00 to $60.00 and set an "overweight" rating for the company in a report on Wednesday, August 6th. Wall Street Zen downgraded shares of Semler Scientific from a "buy" rating to a "sell" rating in a research note on Thursday, May 22nd. Maxim Group raised shares of Semler Scientific to a "strong-buy" rating and set a $95.00 target price for the company in a research note on Wednesday, July 9th. Finally, Benchmark started coverage on shares of Semler Scientific in a research note on Tuesday, July 8th. They set a "buy" rating and a $101.00 target price for the company. One research analyst has rated the stock with a Strong Buy rating and three have issued a Buy rating to the stock. According to MarketBeat, the company currently has an average rating of "Buy" and an average target price of $81.75.

Semler Scientific Stock Performance

Shares of SMLR traded up $0.24 during mid-day trading on Wednesday, hitting $28.31. The stock had a trading volume of 286,972 shares, compared to its average volume of 671,197. The company has a debt-to-equity ratio of 0.25, a current ratio of 0.60 and a quick ratio of 0.58. Semler Scientific Inc. has a 52 week low of $21.77 and a 52 week high of $81.56. The firm has a market cap of $419.16 million, a P/E ratio of 11.73 and a beta of 1.39. The business has a fifty day moving average price of $35.82 and a 200-day moving average price of $36.15.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last posted its earnings results on Monday, August 4th. The company reported $5.04 earnings per share for the quarter, topping analysts' consensus estimates of ($0.27) by $5.31. The business had revenue of $8.22 million for the quarter, compared to analyst estimates of $8.10 million. Semler Scientific had a net margin of 86.20% and a return on equity of 43.84%.

Semler Scientific Company Profile

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.